Telemedicine and Diabetic Retinopathy: Review of Published Screening Programs
Journal Title: Journal of Endocrinology and Diabetes - Year 2015, Vol 2, Issue 4
Abstract
Background: Diabetic Retinopathy (DR) is a leading cause of blindness worldwide even though successful treatments exist. Improving screening and treatment could avoid many cases of vision loss. However, due to an increasing prevalence of diabetes, traditional in-person screening for DR for every diabetic patient is not feasible. Telemedicine is one viable solution to provide high-quality and efficient screening to large number of diabetic patients. Purpose: To provide a narrative review of large DR telemedicine screening programs. Methods: Articles were identified through a comprehensive search of the English-language literature published between 2000 and 2014. Telemedicine screening programs were included for review if they had published data on at least 150 patients and had available validation studies supporting their model. Screening programs were then categorized according to their American Telemedicine Association Validation Level. Results: Seven programs from the US and abroad were identified and included in the review. Three programs were Category 1 programs (Ophdiat, EyePacs, and Digiscope), two were Category 2 programs (Eye Check, NHS Diabetic Eye Screening Program), and two were Category 3 programs (Joslin Vision Network, Alberta Screening Program). No program was identified that claimed category 4 status. Programs ranged from community or city level programs to large nationwide programs including millions of individuals. The programs demonstrated a high level of clinical accuracy in screening for DR. There was no consensus amongst the programs regarding the need for dilation, need for stereoscopic images, or the level of training for approved image graders. Conclusion: Telemedicine programs have been clinically validated and successfully implemented across the globe. They can provide a high-level of clinical accuracy for screening for DR while improving patient access in a cost-effective and scalable manner.
Authors and Affiliations
Paula A Newman-Casey, Maria A Woodward, Kevin Tozer
Keywords
Related Articles
- EP ID EP333270
- DOI 10.15226/2374-6890/2/4/00131
- Views 86
- Downloads 0
Favorable Effect of Bromocriptine and Pentoxifylline in Mild Graves Disease Orbitopathy: A Randomized, Open, Clinical Trial
Background:Graves’ orbitopathy (GO) is the most frequent extra thyroidal manifestation of Graves’ disease. Treatment for mild cases consists in euthyroidism restoration and topical treatments. Aim: To evaluate the effec...
Thyroid-Induced Toxicity of Check-Point Inhibitors Immunotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer
Immunotherapy represents a new strategy in the fight against cancer diseases based on the key role that immune system plays to identify and destroy foreign or abnormal cells in the body, including tumor cells. Nowadays,...
An Innovative Approach to Improve Diabetes Management in Accountable Care Organizations
As the Affordable Care Act becomes more widely operational across the United States, the expectation is that all citizens will benefit from better access to quality healthcare. This broad-based prospect of benefit is esp...
Several Types of Somatic Mutations Induce Autonomous Production of Aldosterone in Primary Aldosteronism
It is well known that primary aldosteronism (PA) is the most common form of secondary hypertension, and also that aldosterone-producing adenoma (APA) and bilateral hyperaldosteronism (idiopathic hyperaldosteronism: IHA)...
Registry Study for Type 2 Diabetes Mellitus in a Diabetic Center in Saudi Arabia with Comparative Analysis for Controlled Versus Uncontrolled Cases
Background Aims: Comparative analysis of 109 controlled cases versus 120 uncontrolled cases to see the outcome for different treatment methods in type 2 Diabetes Mellitus. Materials and Methods: The study was conducted i...